CVB homepage

American College of Cardiology President Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI, and professor of medicine at Icahn School of Medicine at Mount Sinai, gave a key note presentation on coronary inflammation at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 meeting. She said inflammation is a growing area of interest as new drugs work their way through trials and clinicians learn the important of using existing methods to lower this residual risk factor for heart disease.

Coronary inflammation may play a critical role in the prevention and treatment of cardiovascular disease. American College of Cardiology President Roxana Mehran, MD, spoke to Cardiovascular Business about this topic at TCT 2026.

Shahab Moossavi, MD

Shahab Moossavi, MD, is remembered as a "dedicated physician who made a meaningful difference in the lives of his patients and the colleagues who worked alongside him." He was 51 years old.

Remedy Robotics N1 System

Remedy Robotics has developed an AI-powered robotic platform and software suite that can be used before and during endovascular procedures. The company plans on using this funding round to ramp up clinical research, deploy prototypes and more. 

Medicare physician fee schedule reform is needed according to the AMA and other medical societies in order to afford the care provided and keep access to care open for Medicare patients. Photos by Dave Fornell

Dozens of medical societies have joined the AMA to warn that payment cuts are having a negative impact on patient access and practice sustainability. 

Tandem Diabetes Care Tandem Mobi tubeless insulin delivery system

Patients with a Tandem Mobi insulin pump will soon be able to choose between two wear options—tubed and tubeless—with the same device. Tubeless insulin delivery can last up to seven days.

merger acquisition M&A business

Medtronic, a longtime investor in Contego Medical, says it is on its way to being "an undisputed leader in carotid revascularization."

Innovation at work

Curtiss Stinis, MD, has been performing TAVR for nearly two decades. He says the new policies from CMS that expand coverage for asymptomatic patients represent a "momentous step forward" for heart patients with severe aortic stenosis.